Mitochondrial disease: when the powerhouse goes awry.

Knowledge of and interest in mitochondrial disease is relatively recent. The first diagnosis of a mitochondrial cytopathy occurred in 1962. Since then, researchers have elucidated hundreds of types of mutant mitochondrial DNA and mapped their repercussions. This article walks the reader through the basics of mitochondrial function--normal and mutant. Mitochondrial cytopathies appear first in organs with high-energy needs; once a threshold of mutant mitochondrial DNA is exceeded, manifestations can be single or multisystem conditions. Although these conditions are currently incurable, some therapies aimed at enhancing mitochondrial function or scavenging free radicals may help individual patients. Certain nonpharmacological therapies should be employed in all patients. Research findings suggest that mitochondrial functioning may have a greater role in other pathologies than previously assumed.

[1]  Marni J. Falk,et al.  A modern approach to the treatment of mitochondrial disease , 2009, Current treatment options in neurology.

[2]  Y. Li,et al.  Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells , 2009, Nature.

[3]  D. Wallace,et al.  The pathophysiology of mitochondrial disease as modeled in the mouse. , 2009, Genes & development.

[4]  S. Jou,et al.  Mitochondrial dysfunction and psychiatric disorders. , 2009, Chang Gung medical journal.

[5]  Ferdinando Palmieri,et al.  Diseases caused by defects of mitochondrial carriers: a review. , 2008, Biochimica et biophysica acta.

[6]  Robert W. Taylor,et al.  Prevalence of mitochondrial DNA disease in adults , 2008, Annals of neurology.

[7]  K. Sobue,et al.  Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy , 2007, Journal of Anesthesia.

[8]  A. M. Salio,et al.  Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes) , 2004, Clinical neuropharmacology.

[9]  B. Cohen,et al.  Treatment of Mitochondrial Cytopathies , 2001, Seminars in neurology.

[10]  M. Tarnopolsky,et al.  Creatine monohydrate increases strength in patients with neuromuscular disease , 1999, Neurology.

[11]  H. Reichmann,et al.  Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy , 1998, Journal of Neurology.

[12]  P. Matthews,et al.  Effects of aerobic training in patients with mitochondrial myopathies , 1998, Neurology.

[13]  M. Tarnopolsky,et al.  A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies , 1997, Muscle & nerve.

[14]  J. Arenas,et al.  Plasma carnitine insufficiency and effectiveness of L‐carnitine therapy in patients with mitochondril myopathy , 1993, Muscle & nerve.

[15]  Y. Mashima,et al.  Remission of Leber's hereditary optic neuropathy with idebenone , 1992, The Lancet.

[16]  N. Nishitani,et al.  Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke‐like episodes (MELAS) , 1991, Acta neurologica Scandinavica.

[17]  N. Bresolin,et al.  Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial , 1990, Journal of the Neurological Sciences.

[18]  S. Kuroda,et al.  Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone , 1989, Journal of the Neurological Sciences.

[19]  U. Muscatello,et al.  Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine. , 1989, Biochemical and biophysical research communications.

[20]  Richard P. Lewis,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2016 .

[21]  N. Chu,et al.  Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. , 1997, European neurology.

[22]  G. Danta,et al.  Chronic progressive external ophthalmoplegia. , 1975, Brain : a journal of neurology.